Andreas Halvorsen: portfolio of Viking Global Investors
Andreas Halvorsen leads Viking Global Investors, a hedge fund that analyzes stocks worldwide and combines long and short positions.
Source: 13F filing with the US Securities and Exchange Commission dated Feb 14, 2022. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary Amended on May 16, 2022 – the version known today is shown.
You are looking at Q4 2021. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 34.5B USD
- Positions
- 105
- Share of the ten largest
- 37.6%
The ten largest positions Q4 2021
- Ginkgo Bioworks Holdings Inc 8.2%unchanged
- GE Aerospace 4.9%▲ +6.6%
- T-Mobile US 4.4%▲ +28.6%
- Humana 3.6%▼ −11.4%
- Brookfield Asset Mgmt Inc 3.1%▲ +3.6%
- Microsoft 2.9%▼ −19.5%
- Parker Hannifin 2.8%▼ −1.4%
- Amazon 2.7%▲ +37.1%
- Roivant Sciences Ltd 2.6%new
- Visa Inc. 2.5%▲ +50.6%
Show all positions of this quarter
Choose a quarter (54 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
- Q3 2016
- Q2 2016
- Q1 2016
- Q4 2015
- Q3 2015
- Q2 2015
- Q1 2015
- Q4 2014
- Q3 2014
- Q2 2014
- Q1 2014
- Q4 2013
- Q3 2013
- Q2 2013
All positions Q4 2021
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| Ginkgo Bioworks Holdings Inc | 8.2% | 339,055,144 | 2.8B USD | unchanged | Q3 2021 2 quarters |
| GE GE Aerospace | 4.9% | 18,041,156 | 1.7B USD | +6.6% increased | Q4 2020 5 quarters |
| TMUS T-Mobile US | 4.4% | 13,148,287 | 1.5B USD | +28.6% increased | Q1 2020 8 quarters |
| HUM Humana | 3.6% | 2,663,368 | 1.2B USD | −11.4% reduced | Q2 2021 3 quarters |
| Brookfield Asset Mgmt Inc | 3.1% | 17,603,102 | 1.1B USD | +3.6% increased | Q2 2021 3 quarters |
| MSFT Microsoft | 2.9% | 2,932,762 | 986.3M USD | −19.5% reduced | Q2 2016 23 quarters |
| PH Parker Hannifin | 2.8% | 3,056,921 | 972.5M USD | −1.4% reduced | Q2 2020 7 quarters |
| AMZN Amazon | 2.7% | 278,199 | 927.6M USD | +37.1% increased | Q2 2015 27 quarters |
| Roivant Sciences Ltd | 2.6% | 88,238,700 | 889.4M USD | new | Q4 2021 1 quarter |
| V Visa Inc. | 2.5% | 3,971,579 | 860.7M USD | +50.6% increased | Q3 2016 22 quarters |
| Api Group Corp | 2.5% | 33,333,333 | 859.0M USD | unchanged | Q2 2020 7 quarters |
| Adaptive Biotechnologies Cor | 2.4% | 29,993,708 | 841.6M USD | unchanged | Q2 2019 11 quarters |
| BSX Boston Scientific | 2.3% | 18,961,501 | 805.5M USD | +176.1% increased | Q3 2018 14 quarters |
| TWLO Twilio | 2.3% | 2,980,398 | 784.9M USD | new | Q4 2021 1 quarter |
| CMCSA Comcast | 2.1% | 14,213,091 | 715.3M USD | +39.7% increased | Q3 2021 2 quarters |
| CB Chubb Limited | 2.1% | 3,691,765 | 713.7M USD | +21.4% increased | Q1 2020 8 quarters |
| CNC Centene Corporation | 2.1% | 8,618,638 | 710.2M USD | −12.8% reduced | Q2 2018 15 quarters |
| Coupa Software Inc | 1.9% | 4,168,030 | 658.8M USD | +6.4% increased | Q1 2021 4 quarters |
| FTV Fortive | 1.9% | 8,484,942 | 647.3M USD | −21.5% reduced | Q3 2019 10 quarters |
| META Meta Platforms | 1.8% | 1,886,516 | 634.5M USD | +10.6% increased | Q4 2020 5 quarters |
| Guardant Health Inc | 1.5% | 5,074,389 | 507.5M USD | +3.7% increased | Q3 2019 10 quarters |
| WDAY Workday, Inc. | 1.4% | 1,751,589 | 478.5M USD | new | Q4 2021 1 quarter |
| AON Aon plc | 1.3% | 1,510,517 | 454.0M USD | new | Q4 2021 1 quarter |
| Bridgebio Pharma Inc | 1.3% | 26,620,991 | 444.0M USD | unchanged | Q2 2019 11 quarters |
| UBER Uber | 1.3% | 10,584,794 | 443.8M USD | +65.6% increased | Q3 2021 2 quarters |
| AMP Ameriprise Financial | 1.3% | 1,453,796 | 438.6M USD | +3.8% increased | Q1 2021 4 quarters |
| Royalty Pharma PLC | 1.2% | 10,315,378 | 411.1M USD | +149.1% increased | Q2 2020 7 quarters |
| Figs Inc | 1.2% | 14,742,689 | 406.3M USD | unchanged | Q2 2021 3 quarters |
| Avantor Inc | 1.1% | 8,787,342 | 370.3M USD | +23.4% increased | Q2 2019 11 quarters |
| RIVN Rivian Automotive | 1.0% | 3,204,389 | 332.3M USD | new | Q4 2021 1 quarter |
| DE Deere & Company | 0.9% | 933,418 | 320.1M USD | +29.9% increased | Q1 2021 4 quarters |
| Global E Online Ltd | 0.9% | 5,038,891 | 319.4M USD | new | Q4 2021 1 quarter |
| ZBH Zimmer Biomet | 0.9% | 2,496,245 | 317.1M USD | −26.8% reduced | Q3 2020 6 quarters |
| Hdfc Bank Ltd | 0.9% | 4,852,938 | 315.8M USD | +189.0% increased | Q3 2021 2 quarters |
| BKNG Booking Holdings | 0.9% | 128,278 | 307.8M USD | −4.6% reduced | Q2 2021 3 quarters |
| AIZ Assurant | 0.8% | 1,723,771 | 268.7M USD | −5.2% reduced | Q2 2019 11 quarters |
| Laboratory Corp Amer HLDGS | 0.8% | 850,147 | 267.1M USD | +7.4% increased | Q3 2020 6 quarters |
| JD JD.com (ADR) | 0.8% | 3,765,921 | 263.9M USD | −48.4% reduced | Q2 2021 3 quarters |
| Tenet Healthcare Corp | 0.8% | 3,211,241 | 262.3M USD | −4.3% reduced | Q1 2021 4 quarters |
| Mcdonalds Corp | 0.7% | 958,248 | 256.9M USD | −68.0% reduced | Q3 2021 2 quarters |
| Biomarin Pharmaceutical Inc | 0.7% | 2,869,947 | 253.6M USD | new | Q4 2021 1 quarter |
| Match Group Inc New | 0.7% | 1,899,574 | 251.2M USD | +39.2% increased | Q4 2020 5 quarters |
| Lithia Mtrs Inc | 0.7% | 791,084 | 234.9M USD | −1.5% reduced | Q1 2021 4 quarters |
| Inhibrx Inc | 0.7% | 5,305,866 | 231.7M USD | unchanged | Q3 2020 6 quarters |
| WTW Willis Towers Watson | 0.7% | 962,328 | 228.5M USD | −17.0% reduced | Q3 2021 2 quarters |
| Fleetcor Technologies Inc | 0.6% | 983,391 | 220.1M USD | −60.2% reduced | Q3 2020 6 quarters |
| PANW Palo Alto Networks | 0.6% | 395,157 | 220.0M USD | −69.0% reduced | Q4 2020 5 quarters |
| MRSH Marsh McLennan | 0.6% | 1,261,570 | 219.3M USD | +9.1% increased | Q4 2020 5 quarters |
| TTWO Take-Two Interactive | 0.6% | 1,203,961 | 214.0M USD | new | Q4 2021 1 quarter |
| Farfetch Ltd | 0.6% | 5,946,096 | 198.8M USD | −48.5% reduced | Q3 2021 2 quarters |
| Zai Lab Ltd | 0.6% | 3,018,958 | 189.7M USD | +2.9% increased | Q1 2021 4 quarters |
| Intellia Therapeutics Inc | 0.5% | 1,579,536 | 186.8M USD | +23.4% increased | Q2 2021 3 quarters |
| TSLA Tesla, Inc. | 0.5% | 173,672 | 183.5M USD | −54.8% reduced | Q3 2021 2 quarters |
| PODD Insulet Corporation | 0.5% | 678,194 | 180.4M USD | −33.1% reduced | Q3 2020 6 quarters |
| Zentalis Pharmaceuticals Inc | 0.5% | 2,118,284 | 178.1M USD | unchanged | Q2 2020 7 quarters |
| Zoominfo Technologies Inc | 0.5% | 2,706,305 | 173.7M USD | −29.9% reduced | Q2 2021 3 quarters |
| FDX FedEx | 0.5% | 655,242 | 169.5M USD | new | Q4 2021 1 quarter |
| AIG American International Group | 0.5% | 2,903,295 | 165.1M USD | new | Q4 2021 1 quarter |
| CRL Charles River Laboratories | 0.4% | 390,129 | 147.0M USD | +119.9% increased | Q1 2021 4 quarters |
| Catalent Inc | 0.4% | 1,139,354 | 145.9M USD | −2.0% reduced | Q1 2018 16 quarters |
| NOW ServiceNow | 0.4% | 224,261 | 145.6M USD | −59.9% reduced | Q4 2020 5 quarters |
| LI Li Auto | 0.4% | 4,485,985 | 144.0M USD | new | Q4 2021 1 quarter |
| Molina Healthcare Inc | 0.4% | 447,686 | 142.4M USD | −52.1% reduced | Q3 2019 10 quarters |
| Peloton Interactive Inc | 0.4% | 3,951,576 | 141.3M USD | −39.1% reduced | Q2 2021 3 quarters |
| TMO Thermo Fisher Scientific | 0.4% | 211,058 | 140.8M USD | +15.8% increased | Q2 2020 7 quarters |
| RUN Sunrun | 0.4% | 3,823,259 | 131.1M USD | −56.6% reduced | Q1 2021 4 quarters |
| Acadia Healthcare Company In | 0.4% | 2,090,576 | 126.9M USD | −0.6% reduced | Q4 2020 5 quarters |
| Procept Biorobotics Corp | 0.4% | 4,907,892 | 122.7M USD | unchanged | Q3 2021 2 quarters |
| BMY Bristol Myers Squibb | 0.3% | 1,815,619 | 113.2M USD | −74.1% reduced | Q3 2020 6 quarters |
| Karuna Therapeutics Inc | 0.3% | 863,664 | 113.1M USD | −0.6% reduced | Q3 2020 6 quarters |
| SE Sea Limited (ADR) | 0.3% | 440,129 | 98.5M USD | new | Q4 2021 1 quarter |
| Adapthealth Corp | 0.3% | 3,949,783 | 96.6M USD | −3.0% reduced | Q2 2021 3 quarters |
| 4D Molecular Therapeutics In | 0.3% | 3,937,914 | 86.4M USD | unchanged | Q4 2020 5 quarters |
| WDC Western Digital | 0.2% | 1,311,029 | 85.5M USD | new | Q4 2021 1 quarter |
| Pvh Corporation | 0.2% | 768,809 | 82.0M USD | −33.8% reduced | Q2 2020 7 quarters |
| Zillow Group Inc | 0.2% | 1,258,215 | 80.3M USD | new | Q4 2021 1 quarter |
| IFF International Flavors & Fragrances | 0.2% | 510,985 | 77.0M USD | new | Q4 2021 1 quarter |
| XYZ Block, Inc. | 0.2% | 454,947 | 73.5M USD | new | Q4 2021 1 quarter |
| XPEV XPeng | 0.2% | 1,456,496 | 73.3M USD | new | Q4 2021 1 quarter |
| Amedisys Inc | 0.2% | 391,131 | 63.3M USD | new | Q4 2021 1 quarter |
| KKR KKR & Co. | 0.2% | 806,081 | 60.1M USD | new | Q4 2021 1 quarter |
| BEKE KE Holdings | 0.2% | 2,920,256 | 58.8M USD | new | Q4 2021 1 quarter |
| PHM PulteGroup | 0.2% | 913,668 | 52.2M USD | new | Q4 2021 1 quarter |
| Talaris Therapeutics Inc | 0.1% | 3,289,617 | 50.3M USD | unchanged | Q2 2021 3 quarters |
| Biohaven Pharmactl Hldg Co L | 0.1% | 348,783 | 48.1M USD | new | Q4 2021 1 quarter |
| Olaplex HLDGS Inc | 0.1% | 1,613,189 | 47.0M USD | −46.6% reduced | Q3 2021 2 quarters |
| Edgewise Therapeutics Inc | 0.1% | 2,727,249 | 41.7M USD | unchanged | Q1 2021 4 quarters |
| Pmv Pharmaceuticals Inc | 0.1% | 1,790,284 | 41.4M USD | unchanged | Q3 2020 6 quarters |
| Icosavax Inc | 0.1% | 1,796,800 | 41.1M USD | −3.0% reduced | Q3 2021 2 quarters |
| Rallybio Corp | 0.1% | 4,194,777 | 40.0M USD | unchanged | Q3 2021 2 quarters |
| APO Apollo Global Management | 0.1% | 538,212 | 39.0M USD | new | Q4 2021 1 quarter |
| Pharvaris N V | 0.1% | 2,455,536 | 38.8M USD | +2.7% increased | Q1 2021 4 quarters |
| Orion Acquisition Corp | 0.1% | 3,669,272 | 36.1M USD | −0.1% reduced | Q1 2021 4 quarters |
| Vtex | < 0.1% | 3,023,280 | 32.4M USD | −0.6% reduced | Q3 2021 2 quarters |
| Kinnate Biopharma Inc | < 0.1% | 1,820,462 | 32.3M USD | unchanged | Q4 2020 5 quarters |
| Nuvalent Inc | < 0.1% | 1,647,671 | 31.4M USD | unchanged | Q3 2021 2 quarters |
| Abiomed Inc | < 0.1% | 82,572 | 29.7M USD | new | Q4 2021 1 quarter |
| Celldex Therapeutics Inc New | < 0.1% | 757,881 | 29.3M USD | −0.6% reduced | Q3 2021 2 quarters |
| Day One Biopharmaceuticals I | < 0.1% | 1,157,424 | 19.5M USD | −4.5% reduced | Q2 2021 3 quarters |
| Tdcx Inc | < 0.1% | 1,014,497 | 19.4M USD | new | Q4 2021 1 quarter |
| On Hldg AG | < 0.1% | 300,000 | 11.3M USD | unchanged | Q3 2021 2 quarters |
| Meli Kaszek Pioneer Corp | < 0.1% | 880,185 | 10.2M USD | −12.0% reduced | Q3 2021 2 quarters |
| Lianbio | < 0.1% | 1,500,000 | 9.2M USD | new | Q4 2021 1 quarter |
| SEMA4 Holdings Corp | < 0.1% | 1,226,307 | 5.5M USD | −59.1% reduced | Q3 2021 2 quarters |
| Gracell Biotechnologies Inc | < 0.1% | 491,647 | 3.0M USD | −63.8% reduced | Q1 2021 4 quarters |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Plus 2 positions in convertible bonds and bonds worth 217.0M USD as reported – not included in the weights.
Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.
- Guardant Health Inc principal 120.0M USD 122.0M USD
- Coupa Software Inc principal 100.0M USD 95.0M USD
Breakdown by sector
- Industrials 12.7%
- Health Care 10.6%
- Financials 10.2%
- Communication Services 9.0%
- Technology 7.8%
- Consumer Discretionary 5.2%
- Materials 0.2%
- not in our coverage 44.3%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors